Molecular characterization of response to etrolizumab and anti-TNF reveals treatment resistance in ulcerative colitis is associated with the abundance of residual neutrophil subsets and inflammatory fibroblast populations

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Ecology

Medicine

Epidemiology

Immunology

Show all topics

DOI

10.1101/2024.07.02.601267

License

CC-BY-NC-ND

Other Formats

PDF